Every morning I sit at the breakfast table with my mother. She moved to New York about five years ago and having had her so close to me makes New York feel even more like home. Our morning meal, whipped up by my mom, is served up alongside a cup of Nepali chiya—a traditional black … Read more
A version of this article also appeared in the It’s Not Just You newsletter.Sign up here to receive a new edition every Sunday. I’m a tech believer. My first job with TIME was to set up new communications systems and convince cranky foreign correspondents to trust them. Alexa and Google Home have colonized my apartment. … Read more
Experts say the doses are not dangerous, but their expiration means their effectiveness could be in question. View original article Contributor: Brittany Shammas
The trial in 10 countries in Latin America and Europe will continue, and a final result is not expected until the end of June. The CureVac vaccine is of key importance to Europe, which has preordered 225 million doses. View original article Contributor: Carolyn Y. Johnson
Ending masking and social distancing has led to an increase in common viruses among children who haven’t been exposed to them. RSV, a winter illness, is now on the rise, and some doctors are reporting increased hospitalizations. View original article Contributor: Amy Goldstein
Experts say the doses are not dangerous, but their expiration means their effectiveness could be in question. View original article Contributor: Brittany Shammas
The trial in 10 countries in Latin America and Europe will continue, and a final result is not expected until the end of June. The CureVac vaccine is of key importance to Europe, which has preordered 225 million doses. View original article Contributor: Carolyn Y. Johnson
Ending masking and social distancing has led to an increase in common viruses among children who haven’t been exposed to them. RSV, a winter illness, is now on the rise, and some doctors are reporting increased hospitalizations. View original article Contributor: Amy Goldstein
The pandemic revealed the glaring weaknesses of the world’s premier public health agency — and just how much work it would take to reform it. View original article Contributor: Jeneen Interlandi and Brian Rea
A preliminary analysis estimated that CureVac’s mRNA vaccine had an efficacy of just 47 percent. “This is pretty devastating for them,” one expert said. View original article Contributor: Carl Zimmer